Trademark Overview
On Tuesday, March 5, 2024, a trademark application was filed for LILIUMX with the United States Patent and Trademark Office. The USPTO has given the LILIUMX trademark a serial number of 79397609. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, October 22, 2024. This trademark is owned by Valink Therapeutics Inc.. The LILIUMX trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceuticals, medical and veterinary preparations; pharmaceutical drugs; pharmaceutical preparations; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; anti-cancer drugs; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of tumours; chemotherapeutics; biotechnological preparations for medical use; antibodies.
Chemicals for use in industry and science; biological preparations for use in industry and science; proteins for use in science; proteins for use in industry; proteins for detecting antibodies [other than for medical use]; proteins for binding antibodies [other than for medical use]; immunological antibodies, other than for medical use; chemical substances for use in the biotechnological industry; chemicals for use in the pharmaceutical industry; chemical substances for use in the production of drugs; chemicals for use in scientific research [other than medical or veterinary]; chemicals for use in biotechnological product development.
Scientific and technological services and research and design relating thereto; biotechnology research; biological research, clinical research and medical research; scientific research for medical purposes; research and development of vaccines and medicines; scientific research for medical purposes in the area of cancerous diseases; research and development services in the field of antibodies; research and development in the pharmaceutical and biotechnology fields; biotechnology testing; research relating to biotechnology; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research and development for the pharmaceutical industry; conducting clinical trials for pharmaceutical products; testing of pharmaceuticals; biochemistry drug services; biochemistry consultancy; biochemistry research services; biochemical research and development; re...
